【24h】

Which patients should be tested for viruses on bronchoalveolar lavage fluid?

机译:应该在支气管肺泡灌洗液上进行病毒测试哪些患者?

获取原文
获取原文并翻译 | 示例
       

摘要

Bronchoalveolar lavage (BAL) is a major diagnostic tool in lung diseases, including viral respiratory infections. We aimed to better define the situations where viral tests should be performed on BAL fluid (BALF). We retrospectively studied all cases where viral tests [immunofluorescence, immunocytochemistry, viral culture, and/or polymerase chain reaction (PCR)] were performed on BALF during a period of 1 year (2008) in our institution. We compared the characteristics of patients with virus-positive versus virus-negative BALF. Of the 636 BALF samples sent to the microbiology laboratory, 232 underwent viral tests. Of these, 70 (30 %) were positive and identified 85 viruses: herpes simplex virus (HSV)-1 (n = 27), cytomegalovirus (CMV, n = 23), Epstein-Barr virus (EBV, n = 18), human herpesvirus (HHV)-6 (n = 12), respiratory syncytial virus (RSV, n = 3), rhinovirus (n = 1), and adenovirus (n = 1). The variables associated with positive viral tests on univariate analysis were immunosuppression [human immunodeficiency virus (HIV), corticosteroids >10 mg/day for ≥3 weeks, or other immunosuppressive therapy], ground-glass attenuations on computed tomography (CT) scanning, late-onset ventilator-associated pneumonia (VAP), and durations of (i) hospital stay, (ii) intensive care unit (ICU) stay, and (iii) mechanical ventilation before BAL (p < 0.01 for each comparison). On multivariate analysis, only immunosuppression [odds ratio (OR) 6.4, 95 % confidence interval (CI) [2.8-14.3], p < 0.0001] and ground-glass attenuations (OR 3.7, 95 % CI [1.8-7.7], p = 0.0004) remained associated with virus-positive BAL. None of the viral tests performed on BALF for the initial assessment of diffuse infiltrative lung disease (n = 15) was positive. PCR improved the diagnostic yield of viral tests on BALF by 50 %. Testing for viruses on BALF should be mostly restricted to immunocompromised patients with acute respiratory diseases and/or patients with unexplained ground-glass attenuations on CT scanning.
机译:Bronchoalveolar灌洗(BAL)是肺部疾病的主要诊断工具,包括病毒性呼吸道感染。我们的目标是更好地定义病毒试验应在BAL流体(BALF)上进行的情况。我们回顾性地研究了病毒试验[免疫荧光,免疫细胞化学,病毒培养和/或聚合酶链反应(PCR)在我们机构的1年(2008年)中进行了病毒试验的情况。我们比较了病毒阳性与病毒阴性BALF患者的特征。在送到微生物学实验室的636个BALF样品中,232个经过病毒性测试。其中70(30%)是阳性的并鉴定85病毒:疱疹病毒(HSV)-1(n = 27),塞细胞病毒(CMV,N = 23),Epstein-Barr病毒(EBV,N = 18),人疱疹病毒(HHV)-6(n = 12),呼吸合胞病毒(RSV,N = 3),鼻病毒(n = 1)和腺病毒(n = 1)。与单变量分析的阳性病毒试验相关的变量是免疫抑制[人免疫缺陷病毒(HIV),皮质类固醇> 10毫克/天≥3周,或其他免疫抑制治疗],计算机断层扫描(CT)扫描上的地面玻璃衰减 - 组件呼吸机相关的肺炎(VAP)和(i)住院住院的持续时间,(ii)重症监护单位(ICU)停留,(iii)BAL之前的机械通气(每次比较P <0.01)。在多变量分析上,仅免疫抑制[差距(或)6.4,95%置信区间(CI)[2.8-14.3],P <0.8-14.3],P <0.0001]和研磨玻璃衰减(或3.7,95%CI [1.8-7.7],P = 0.0004)与病毒阳性BAL保持联系。对于衍射渗透肺病的初始评估(n = 15)的初始评估的BALF中没有进行的病毒试验均为阳性。 PCR改善了50%的病毒试验的诊断产量。对BALF的病毒测试应主要限于免疫呼吸疾病和/或患者对CT扫描的无法解释的地玻璃衰减患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号